More about GlaxoSmithKline Pharmaceuticals Limited

Technicals for GlaxoSmithKline Pharmaceuticals Limited

The PSAR maintains its bearish stance, establishing a resistance level that could...

Regulatory Filings for GlaxoSmithKline Pharmaceuticals Limited

The list of all important regulatory filings for GlaxoSmithKline Pharmaceuticals Limited which...

Last Updated:

2025-09-04 20:59

Published	Title	Summary
2025-01-20 15:40:54	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2025-01-15 12:39:50	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2024-07-22 13:05:12	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .
2024-05-17 14:11:26	Record Date	GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date...
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 31-May-2024.

DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.

If you have enjoyed reading, spread the word:

Good prospects: